Recruiting studies: Patient With Dyslipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreat
Phase 1 · 1 location(s) · GeneCradle Inc · NCT05860569 Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Phase N/A · 1 location(s) · Daewoong Pharmaceutical Co. LTD. · NCT06647888 A Dose-exploration Study of EDP167 in HoFH
Phase 2 · 1 location(s) · Eddingpharm (Zhuhai) Co., Ltd. · NCT07489209 Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreat
Phase 4 · 1 location(s) · Jianyin Zhou · NCT07720232 Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648 Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Phase 2 · 4 location(s) · Ribocure Pharmaceuticals AB · NCT06797401 A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Phase 2 · 1 location(s) · Marea Therapeutics · NCT07199309 Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
NA · 1 location(s) · Taipei Medical University · NCT07692438 High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Phase 4 · 1 location(s) · Samsung Medical Center · NCT05845424 A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
Phase 4 · 10 location(s) · Kowa Company, Ltd. · NCT07634484 Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
Phase N/A · 1 location(s) · Beijing Tongren Hospital · NCT05644548 Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El
NA · 2 location(s) · Sin Gon Kim · NCT07359105 Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy i
Phase 4 · 1 location(s) · Saint Vincent's Hospital, Korea · NCT06186037 Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support T
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT07400549 Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958 A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
NA · 3 location(s) · University of Connecticut · NCT07238556 The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
Phase 4 · 3 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT06750783 Effect of Ezetimibe on Gut Microbiota
Phase 4 · 1 location(s) · Yonsei University · NCT06784557 A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Phase 3 · 1 location(s) · Gan & Lee Pharmaceuticals. · NCT06780410 Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Phase 2 · 1 location(s) · Chang Gung Memorial Hospital · NCT07307989 A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Phase N/A · 1 location(s) · Ahn-Gook Pharmaceuticals Co.,Ltd · NCT07083206 Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Phase 1 · 16 location(s) · Verve Therapeutics, Inc. · NCT06451770 Pemafibrate for Symptomatic ICAS RCT
NA · 19 location(s) · Tokyo Women's Medical University · NCT07562178 Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT05365425 To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
NA · 1 location(s) · Korea University Anam Hospital · NCT06293417 Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Phase 3 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT05621070 Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07295327 Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients W
NA · 1 location(s) · Colorado Prevention Center · NCT07334834 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · 163 location(s) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined D
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT05365438

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.